sur BASTIDE (EPA:BLC)
Bastide sells its subsidiary EXPERF to the Sapio Group
On May 21, 2026, the Bastide Group announced the sale of New Medical Concept, EXPERF's holding company, to Sapio Group. EXPERF, specializing in home infusion and nutrition, has doubled its revenue since its acquisition by Bastide in 2017, reaching €42 million in 2024-2025 thanks to a network of 28 branches.
This sale is part of the Bastide Group's asset arbitrage strategy, aimed at optimizing its portfolio and strengthening its financial structure. The transaction will help reduce debt and financial expenses, improving the leverage ratio to slightly above 2.5x.
Sapio Group, by strengthening its presence in France with this acquisition, sees EXPERF as a key lever for its European expansion in the healthcare sector.
R. E.
Copyright © 2026 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de BASTIDE